COPD

Could Vascular Dysfunction Be a Primary vs Secondary Feature of COPD?

By

Pulmonology Advisor Contributing Writer

New research suggests chronic obstructive pulmonary disease directly caused by tobacco smoke could be cured.

The Challenges of Pulmonary Rehab in Facilities May Be Overcome in the Home

By

Tori Rodriguez, MA, LPC, AHC

Implementing pulmonary rehabilitation in patients’ homes may address several barriers, including need for referrals, accessibility to centers, and inability to travel because of chronic respiratory disease.

COPD Biomarkers: More Relevant Measures Needed to Predict Prognosis

By

Suzanne Bujara

The objectivity of biomarkers in COPD to predict medication response, disease severity, and prognosis shows promise, but future trials need to examine biomarkers’ response in patients with COPD subtypes.

COPD Subtype Classification: Analysis of the COPDGene Study

By

Virginia A. Schad, PharmD, RPh

Continuous evaluation of participants in the COPDGene study will provide useful insights that will enable better identification of disease subtypes.

Increased Nutrient Intake Linked With Decreased COPD Severity in Elderly Men

By

Pulmonology Advisor Contributing Writer

Among elderly men with COPD, proper intake of fiber, protein, carbohydrate, vitamin C, niacin, and riboflavin was associated with less severe airway impairment.

Varenicline Initially Improves Continuous Abstention in Smokers With COPD

By

Bryant Moeller

Patients who smoked and were hospitalized for a COPD exacerbation had higher rates of continuous abstention when treated with both varenicline and intensive counseling compared with intensive counseling alone.

High Patient Complexity in COPD Associated With Low-Value ICS Prescription

By

Pulmonology Advisor Contributing Writer

Higher patient complexity is associated with incident prescription of low-value inhaled corticosteroids in COPD.

Could COPD Serve as a Marker of Cardiovascular Morbidity, Mortality?

By

Sheila Jacobs

Patients with chronic obstructive pulmonary disease experience significant cardiovascular morbidity and mortality.